Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARS1 | P56192 | 1/20 | 0.75 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.71 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.66 |
| ▸ | NNMT | P40261 | 3/20 | 0.66 |
| ▸ | DOT1L | Q8TEK3 | 5/20 | 0.65 |
| ▸ | NSD2 | O96028 | 3/20 | 0.65 |
| ▸ | SETD7 | Q8WTS6 | 3/20 | 0.65 |
| ▸ | CARM1 | Q86X55 | 3/20 | 0.65 |
| ▸ | PCMT1 | P22061 | 2/20 | 0.65 |
| ▸ | TRDMT1 | O14717 | 2/20 | 0.65 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.65 |
| ▸ | INMT | O95050 | 2/20 | 0.65 |
| ▸ | METTL3 | Q86U44 | 2/20 | 0.65 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.65 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.65 |
| ▸ | METTL14 | Q9HCE5 | 2/20 | 0.65 |
| ▸ | RNMT | O43148 | 1/20 | 0.65 |
| ▸ | TPMT | P51580 | 1/20 | 0.65 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.65 |
| ▸ | SETD2 | Q9BYW2 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14450634 | 0.89 | EHMT2 (0.72) | MARS1PLA2G2AEHMT2NNMTDOT1L | |
| SCHEMBL6408975 | 0.89 | MARS1 (0.80) | MARS1EHMT2NNMTDOT1LNSD2 | |
| SCHEMBL6408983 | 0.89 | MARS1 (0.80) | MARS1EHMT2NNMTDOT1LNSD2 | |
| SCHEMBL18423487 | 0.89 | P2RY1 (0.73) | ADORA1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL1757017 | 0.87 | ADORA1 (0.73) | MARS1PLA2G2ADOT1LADORA1DNPH1 | |
| SCHEMBL19859780 | 0.87 | ADORA1 (0.73) | MARS1PLA2G2ADOT1LADORA1DNPH1 | |
| Adenosine Phosphate SCHEMBL2406483 | 0.87 | P2RY1 (0.81) | EHMT2ADORA1DNPH1PRKAB2TRPM2 | |
| Adenosine SCHEMBL1858293 | 0.87 | DOT1L (0.77) | EHMT2NNMTDOT1LNSD2SETD7 | |
| SCHEMBL2761284 | 0.86 | MARS1 (0.74) | MARS1PLA2G2ADOT1LADORA1DNPH1 | |
| SCHEMBL7757016 | 0.86 | MARS1 (0.73) | MARS1ADORA1DNPH1PRKAB2TRPM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160120894-A1 | USE OF ADENOSINE ASPARTATE IN THE DIFFERENTIAL ACTIVATION OF MACROPHAGES IN INFLAMMATORY-FIBROGENIC PROCESSES AND ITS REVERSAL | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2016-05-05 | — | — | US | claimed |
| US-8507459-B2 | Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer | UNIVERSIDAD NACIONAL AUTONNOMA DE MEXICO (MX) | 2013-08-13 | — | — | US | claimed |
| US-20110105425-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2011-05-05 | — | — | US | claimed |
| EP-2186519-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2010-05-19 | — | — | EP | claimed |
| US-20160120894-A1 | USE OF ADENOSINE ASPARTATE IN THE DIFFERENTIAL ACTIVATION OF MACROPHAGES IN INFLAMMATORY-FIBROGENIC PROCESSES AND ITS REVERSAL | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2016-05-05 | — | — | US | disclosed |
| US-20160120894-A1 | USE OF ADENOSINE ASPARTATE IN THE DIFFERENTIAL ACTIVATION OF MACROPHAGES IN INFLAMMATORY-FIBROGENIC PROCESSES AND ITS REVERSAL | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2016-05-05 | — | — | US | disclosed |
| US-20160120894-A1 | USE OF ADENOSINE ASPARTATE IN THE DIFFERENTIAL ACTIVATION OF MACROPHAGES IN INFLAMMATORY-FIBROGENIC PROCESSES AND ITS REVERSAL | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2016-05-05 | — | — | US | disclosed |
| WO-2014189349-A1 | USE OF ADENOSINE ASPARTATE IN THE DIFFERENTIAL ACTIVATION OF MACROPHAGES IN INFLAMMATORY-FIBROGENIC PROCESSES AND THE REVERSION THEREOF | Universidad Nacional Autónoma de México (MX) | 2014-11-27 | — | — | WO | disclosed |
| WO-2014189349-A1 | USE OF ADENOSINE ASPARTATE IN THE DIFFERENTIAL ACTIVATION OF MACROPHAGES IN INFLAMMATORY-FIBROGENIC PROCESSES AND THE REVERSION THEREOF | Universidad Nacional Autónoma de México (MX) | 2014-11-27 | — | — | WO | disclosed |
| US-8507459-B2 | Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer | UNIVERSIDAD NACIONAL AUTONNOMA DE MEXICO (MX) | 2013-08-13 | — | — | US | disclosed |
| US-8507459-B2 | Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer | UNIVERSIDAD NACIONAL AUTONNOMA DE MEXICO (MX) | 2013-08-13 | — | — | US | disclosed |
| US-8507459-B2 | Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer | UNIVERSIDAD NACIONAL AUTONNOMA DE MEXICO (MX) | 2013-08-13 | — | — | US | disclosed |
| US-20110105425-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2011-05-05 | — | — | US | disclosed |
| US-20110105425-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2011-05-05 | — | — | US | disclosed |
| EP-2186519-A4 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIV MEXICO NACIONAL AUTONOMA (MX) | 2010-09-01 | — | — | EP | disclosed |
| EP-2186519-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2010-05-19 | — | — | EP | disclosed |
| EP-2186519-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2010-05-19 | — | — | EP | disclosed |
| EP-2186519-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2010-05-19 | — | — | EP | disclosed |
| WO-2009031876-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009031876-A1 | USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2009-03-12 | — | — | WO | disclosed |